Yohan Kim

Yohan Kim

Auto-generated profile, based on publicly available information

Yohan Kim

Department of MetaBioHealth, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
YKYohan Kim
Yohan Kim
KKKyojin Kang
Kyojin Kang
SLSeung Bum Lee
Seung Bum Lee
Daekwan SeoDaekwan Seo
Daekwan Seo
SYSangtae Yoon
Sangtae Yoon
DCDongho Choi
Dongho Choi

20 February 2020 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
YKYohan Kim
Yohan Kim
JJJaemin Jeong
Jaemin Jeong
DCDongho Choi
Dongho Choi
Techniques for reprogramming somatic cells create new opportunities for drug screening, disease modeling, artificial organ development, and cell therapy. The development of reprogramming techniques has grown exponentially since the discovery of induced pluripotent stem cells (iPSCs) by the transduction of four factors (OCT3/4, SOX2, c-MYC, and KLF4) in mouse embryonic fibroblasts. Initial studies on iPSCs led to direct-conversion techniques using transcription factors expressed mainly in target cells. However, reprogramming transcription factors with a virus risks integrating viral DNA and can be complicated by oncogenes. To address these problems, many researchers are developing reprogramming methods that use clinically applicable small molecules and growth factors. This review summarizes research trends in reprogramming cells using small molecules and growth factors, including their modes of action.

1 April 2018 in Tissue Engineering Part A
Verified
Journal Article
Closed access
KKKyojin Kang
Kyojin Kang
YKYohan Kim
Yohan Kim
HJHyeryeon Jeon
Hyeryeon Jeon
SLSeung Bum Lee
Seung Bum Lee
JKJi Sook Kim
Ji Sook Kim
DCDongho Choi
Dongho Choi
Three-dimensional (3D) bioprinting technology is a promising new technology in the field of bioartificial organ generation with regard to overcoming the limitations of organ supply. The cell source for bioprinting is very important. Here, we generated 3D hepatic scaffold with mouse-induced hepatocyte-like cells (miHeps), and investigated whether their function was improved after transplantation in vivo. To generate miHeps, mouse embryonic fibroblasts (MEFs) were transformed with pMX retroviruses individually expressing hepatic transcription factors Hnf4a and Foxa3. After 8–10 days, MEFs formed rapidly growing hepatocyte-like colonies. For 3D bioprinting, miHeps were mixed with a 3% alginate hydrogel and extruded by nozzle pressure. After 7 days, they were transplanted into the omentum of Jo2-treated NOD Scid gamma (NSG) mice as a liver damage model. Real-time polymerase chain reaction and immunofluorescence analyses were conducted to evaluate hepatic function. The 3D bioprinted hepatic scaffold (25 × 25 mm) expressed Albumin, and ASGR1 and HNF4a expression gradually increased for 28 days in vitro. When transplanted in vivo, the cells in the hepatic scaffold grew more and exhibited higher Albumin expression than in vitro scaffold. Therefore, combining 3D bioprinting with direct conversion technology appears to be an effective option for liver therapy.

1 January 2017 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
YKYohan Kim
Yohan Kim
KKKyojin Kang
Kyojin Kang
JJJaemin Jeong
Jaemin Jeong
SPSeung Sam Paik
Seung Sam Paik
JKJi Sook Kim
Ji Sook Kim
DCDongho Choi
Dongho Choi
Kim Y, et al. Ann Surg Treat Res. 2017 Feb;92(2):67-72. https://doi.org/10.4174/astr.2017.92.2.67

1 July 2021 in Biomaterials
Verified
Journal Article
Open access
YKYohan Kim
Yohan Kim
YKYoung Won Kim
Young Won Kim
SLSeung Bum Lee
Seung Bum Lee
KKKyojin Kang
Kyojin Kang
SYSangtae Yoon
Sangtae Yoon
JJJaemin Jeong
Jaemin Jeong
Recently, use of cell sheets with bio-applicable fabrication materials for transplantation has been an attractive approach for the treatment of patients with liver failure. However, renewable and scalable cell sources for engineered tissue patches remain limited. We previously reported a new type of proliferating bipotent human chemically derived hepatic progenitor cells (hCdHs) developed by small molecule-mediated reprogramming. Here, we developed a patient-specific hepatic cell sheet constructed from liver biopsy-derived hCdHs on a multiscale fibrous scaffold by combining electrospinning and three-dimensional printing. Analysis of biomaterial composition revealed that the high-density electrospun sheet was superior in increasing the functional properties of hCdHs. Furthermore, the hepatic patch assembled by multilayer stacking with alternate cell sheets of hCdHs and human umbilical vein endothelial cells (HUVECs) recapitulated a liver tissue-like structure, with histological and morphological shape and size similar to those of primary human hepatocytes, and exhibited a significant increase in hepatic functions such as albumin secretion and activity of cytochrome P450 during in vitro hepatic differentiation compared with that in hCdH cells cultured in a two-dimensional monolayer. Interestingly, in the hepatic patch, the induction of functional hepatocytes was associated with both the electrospun fibrous-facilitated oncostatin M signaling and selective activation of AKT signaling by HUVECs. Notably, upon transplantation into a mouse model of therapeutic liver repopulation, the hepatic patch effectively repopulated the damaged parenchyma and induced the restoration of liver function with healthy morphology in the lobe and an improved survival rate (>70%) in mice. Overall, these results suggested that liver biopsy-derived hCdHs can be an efficient alternative source for developing hepatic cell sheets and patches with potential clinical applications in tissue engineering to advance liver regeneration.

30 March 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SPSuk-Hee Park
Suk-Hee Park
BKBo-Kyeong Kang
Bo-Kyeong Kang
JLJi Eun Lee
Ji Eun Lee
SCSeung Woo Chun
Seung Woo Chun
KJKiseok Jang
Kiseok Jang
HKHan Joon Kim
Han Joon Kim